What is the dosage of cyclobenzaprine (a muscle relaxant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cyclobenzaprine Dosage Recommendations

For most patients, the recommended dosage of cyclobenzaprine is 5 mg three times a day, which can be increased to 10 mg three times a day based on individual patient response. 1

Standard Dosing

  • The FDA-approved dosage for cyclobenzaprine is 5 mg three times daily, which can be titrated up to 10 mg three times daily if needed 1
  • Treatment duration should not exceed two to three weeks 1
  • Cyclobenzaprine 5 mg TID is as effective as 10 mg TID but is associated with a lower incidence of sedation 2
  • The onset of relief is typically apparent within 3-4 doses of the 5 mg regimen 2

Special Populations

  • For elderly patients, less frequent dosing should be considered due to increased risk of adverse effects 1
  • For patients with mild hepatic impairment, start with 5 mg and titrate slowly upward 1
  • Cyclobenzaprine is not recommended for patients with moderate to severe hepatic insufficiency due to lack of data 1

Efficacy and Mechanism of Action

  • Cyclobenzaprine is effective in improving muscle spasm, reducing local pain and tenderness, and increasing range of motion in acute, painful musculoskeletal conditions 2
  • The muscle relaxant effect appears to work through activation of locus coeruleus neurons, leading to increased noradrenaline release in the ventral horn of the spinal cord 3
  • Clinical trials have demonstrated that cyclobenzaprine is significantly superior to placebo in relieving signs and symptoms of acute skeletal muscle spasm 4

Adverse Effects and Considerations

  • Sedation and dry mouth are the most common adverse effects and are dose-related 2
  • Over 30% of patients experience drowsiness and sedative-hypnotic effects 5
  • The sedative effect is likely due to cyclobenzaprine's non-competitive antagonism at histamine H1 receptors 5
  • Combination therapy with cyclobenzaprine 5 mg TID plus ibuprofen has not been shown to be superior to cyclobenzaprine 5 mg TID alone in treating acute neck and back pain with muscle spasm 6

Important Clinical Pearls

  • Efficacy of cyclobenzaprine appears to be independent of its sedative effects 2
  • Lower doses (2.5 mg TID) have not been shown to be significantly more effective than placebo 2
  • Cyclobenzaprine represents a cost-effective approach to managing acute muscle spasm due to its rapid symptomatic relief 4
  • Cyclobenzaprine does not provide sedation, analgesia, or amnesia on its own, so it should be administered with appropriate analgesics if pain control is needed 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.